Drugs Slip Past FDA, Sell Unapproved by the Millions (Update1) (Bloomberg.com)
Oct. 11 (Bloomberg) -- Ballay Pharmaceuticals Inc. had a choice nine years ago: seek U.S. approval to sell a prescription decongestant or slip the drug on the market and hope regulators wouldn't order it off.